venlafaxine hydrochloride has been researched along with Clerambault Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alexopoulos, G; Bailine, SH; Bernhardt, E; Briggs, MC; Cullum, CM; Deng, ZD; Dooley, M; Geduldig, ET; Greenberg, RM; Husain, MM; Kaliora, S; Kellner, CH; Knapp, RG; Latoussakis, V; Liebman, LS; Lisanby, SH; McCall, WV; McClintock, SM; Mueller, M; Petrides, G; Prudic, J; Rosenquist, PB; Rudorfer, MV; Sampson, S; Teklehaimanot, AA; Tobias, KG; Weiner, RD; Young, RC | 1 |
Donnelly, NJ; Khouzam, HR | 1 |
1 trial(s) available for venlafaxine hydrochloride and Clerambault Syndrome
Article | Year |
---|---|
Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study.
Topics: Aged; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Neurocognitive Disorders; Neuropsychological Tests; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
1 other study(ies) available for venlafaxine hydrochloride and Clerambault Syndrome
Article | Year |
---|---|
Remission of traumatic brain injury-induced compulsions during venlafaxine treatment.
Topics: Antidepressive Agents, Second-Generation; Craniotomy; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Head Injuries, Closed; Hematoma, Epidural, Cranial; Humans; Male; Middle Aged; Neurocognitive Disorders; Obsessive-Compulsive Disorder; Postoperative Complications; Recurrence; Venlafaxine Hydrochloride | 1998 |